Nephron Pharmaceuticals operates a quality system that runs every shift, on every lot, without exception for the budesonide inhalation suspension and del Nido cardioplegia solution.

Nephron Pharmaceuticals manufactures more than one billion sterile doses each year for patients, providers and partners around the world. At our integrated South Carolina campus, we manufacture generic respiratory products and operate a 503B Outsourcing Facility. We also support pharmaceutical companies from development through commercial supply. Our blow-fill-seal and aseptic platforms handle sterile solutions, suspensions and emulsions. On-site teams support formulation, analytical methods, clinical batches, stability programs, technology transfer and high-volume production. Our campus spans more than 840,000 square feet. We support batch sizes up to 9,000 liters. We welcome product orders, 503B inquiries, contract manufacturing projects, licensing opportunities and international distribution partnerships. Learn more at nephronpharm.com.